Re S. S. Virtanen et al., Alendronate Inhibits Invasion of PC-3 Prostate Cancer Cells by Affecting the Mevalonate Pathway. Cancer Res 2002;62:2708-14. Re K. Sawada et al., Alendronate Inhibits Lysophosphatidic Acid-Induced Migration of Human Ovarian Cancer Cells by Attenuating the Activation of Rho. Cancer Res 2002;62:6015-20 [1] (multiple letters)

Cancer Research

Volumn 64, Issue 8, 2004, Pages 2934-2936

  Andela, Valentine B ^a   Lakkakorpi, Päivi T ^b   Väänänen, H Kalervo ^c   Härkönen, Pirkko L ^c,d   Sawada, Kenjiro ^e   Morishige, Ken Ichirou ^e   Tahara, Masahiro ^e   Kawagishi, Rikako ^e   Ikebuchi, Yoshihide ^e   Tasaka, Keiichi ^e   Murata, Yuji ^e  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Bayer Oy   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d LUND UNIVERSITY   (Sweden)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; LYSOPHOSPHATIDIC ACID; MEVALONIC ACID; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RHO FACTOR;

CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL COMPARTMENTALIZATION; CITRIC ACID CYCLE; ENDOSOME; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN CELL; LETTER; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; METABOLISM; NOTE; PATHOLOGY; PROSTATE TUMOR;

ALENDRONATE; HUMANS; MALE; MEVALONIC ACID; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 2642526130     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)